2.9(top 20%)
impact factor
15.8K(top 1%)
papers
435.7K(top 1%)
citations
212(top 1%)
h-index
3.0(top 20%)
impact factor
21.8K
all documents
459.5K
doc citations
312(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1A review of MRI findings in schizophreniaSchizophrenia Research20012,143
2The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive batterySchizophrenia Research20041,209
3Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICSSchizophrenia Research20041,209
4Schizophrenia, symptomatology and social inference: Investigating “theory of mind” in people with schizophreniaSchizophrenia Research19951,131
5A depression rating scale for schizophrenicsSchizophrenia Research19901,090
6Identification of separable cognitive factors in schizophreniaSchizophrenia Research20041,086
7What does the PANSS mean?Schizophrenia Research20051,083
8A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviorsSchizophrenia Research20051,068
9Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES IIISchizophrenia Research20051,016
10Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) groupSchizophrenia Research2003981
11Strauss (1969) revisited: a psychosis continuum in the general population?Schizophrenia Research2000805
12Schizophrenia, “just the facts” 4. Clinical features and conceptualizationSchizophrenia Research2009799
13The disconnection hypothesisSchizophrenia Research1998797
14Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trialsSchizophrenia Research1999777
15Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychosesSchizophrenia Research2000695
16Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasureSchizophrenia Research2007675
17Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical featuresSchizophrenia Research2004673
18A new instrument for measuring insight: the Beck Cognitive Insight ScaleSchizophrenia Research2004654
19Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophreniaSchizophrenia Research2012648
20Meta-analysis of diffusion tensor imaging studies in schizophreniaSchizophrenia Research2009647
21Theory of mind impairment in schizophrenia: Meta-analysisSchizophrenia Research2009640
22Mismatch negativity in schizophrenia: a meta-analysisSchizophrenia Research2005636
23Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findingsSchizophrenia Research2003613
24Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiologySchizophrenia Research2008610
25Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology ConsortiumSchizophrenia Research2004599
26Decreased volume of left and total anterior insular lobule in schizophreniaSchizophrenia Research2006592
27Seasonality of births in schizophrenia and bipolar disorder: a review of the literatureSchizophrenia Research1997577
28Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysisSchizophrenia Research2010577
29Reliability and validity of a depression rating scale for schizophrenicsSchizophrenia Research1992570
30Mortality and causes of death in schizophrenia in Stockholm County, SwedenSchizophrenia Research2000551
31The Stanley Foundation brain collection and Neuropathology ConsortiumSchizophrenia Research2000524
32IRAOS: an instrument for the assessment of onset and early course of schizophreniaSchizophrenia Research1992521
33Insight in schizophrenia: a meta-analysisSchizophrenia Research2003510
34Meta-analysis of the P300 and P50 waveforms in schizophreniaSchizophrenia Research2004509
35Anatomy of bipolar disorder and schizophrenia: A meta-analysisSchizophrenia Research2010503
36Definition and description of schizophrenia in the DSM-5Schizophrenia Research2013491
37Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common groundSchizophrenia Research1995475
38Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baselineSchizophrenia Research2006473
39The global cognitive impairment in schizophrenia: Consistent over decades and around the worldSchizophrenia Research2013472
40A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controlsSchizophrenia Research2005466
41The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised modelSchizophrenia Research2006466
42Psychotic symptoms in non-clinical populations and the continuum of psychosisSchizophrenia Research2002463
43Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: A meta-analysisSchizophrenia Research2009462
44Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trialsSchizophrenia Research2003449
45A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorderSchizophrenia Research2004439
46From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosisSchizophrenia Research2005433
47Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomesSchizophrenia Research1999428
48The dysconnection hypothesis (2016)Schizophrenia Research2016426
49Amplitude of low-frequency oscillations in schizophrenia: A resting state fMRI studySchizophrenia Research2010425
50Self-stigma, empowerment and perceived discrimination among people with schizophrenia in 14 European countries: The GAMIAN-Europe studySchizophrenia Research2010417